ID

11730

Beschrijving

The purpose of this trial is to evaluate the safety and indicators of efficacy of up to 4 doses of orally administered dabigatran etexilate, administered twice daily, compared to placebo when given in addition to dual antiplatelet treatment in patients with an index event (MI) at high risk for new ischaemic cardiovascular events.

Trefwoorden

  1. 28-07-15 28-07-15 -
  2. 21-11-15 21-11-15 -
Geüploaded op

28 juli 2015

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0 Legacy

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Criteria: RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome

Eligibility criteria

  1. StudyEvent: ODM
    1. Eligibility criteria
Inclusion criteria
Beschrijving

Inclusion criteria

Patients with acute coronary syndromes
Beschrijving

Patients with acute coronary syndromes

Datatype

boolean

with at least one additional risk factor for cardiovascular complications
Beschrijving

with at least one additional risk factor for cardiovascular complications

Datatype

boolean

Alias
UMLS CUI-1
C0741920
Exclusion criteria
Beschrijving

Exclusion criteria

Long term treatment with any other oral anticoagulant
Beschrijving

Long term treatment with any other oral anticoagulant

Datatype

boolean

Alias
UMLS CUI-1
C0354604
Severe/disabling stroke within last 6 months
Beschrijving

Severe/disabling stroke within last 6 months

Datatype

boolean

Alias
UMLS CUI-1
C0038454
Conditions associated with increased bleeding risk
Beschrijving

Conditions associated with increased bleeding risk

Datatype

boolean

Alias
UMLS CUI-1
C3251812
Anaemia
Beschrijving

Anaemia

Datatype

boolean

Alias
UMLS CUI-1
C0002871
Thrombocytopenia
Beschrijving

Thrombocytopenia

Datatype

boolean

Alias
UMLS CUI-1
C0040034
Severe renal impairment
Beschrijving

Severe renal impairment

Datatype

boolean

Alias
UMLS CUI-1
C0035078
Liver disease
Beschrijving

Liver disease

Datatype

boolean

Alias
UMLS CUI-1
C0085605
Positive pregnancy test
Beschrijving

Positive pregnancy test

Datatype

boolean

Alias
UMLS CUI-1
C0549206

Similar models

Eligibility criteria

  1. StudyEvent: ODM
    1. Eligibility criteria
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Inclusion criteria
Acute coronary syndrome
Item
Patients with acute coronary syndromes
boolean
Cardiac risk factor
Item
with at least one additional risk factor for cardiovascular complications
boolean
C0741920 (UMLS CUI-1)
Item Group
Exclusion criteria
Oral Anticoagulants
Item
Long term treatment with any other oral anticoagulant
boolean
C0354604 (UMLS CUI-1)
Stroke
Item
Severe/disabling stroke within last 6 months
boolean
C0038454 (UMLS CUI-1)
Bleeding risk
Item
Conditions associated with increased bleeding risk
boolean
C3251812 (UMLS CUI-1)
Anaemia
Item
Anaemia
boolean
C0002871 (UMLS CUI-1)
Thrombocytopenia
Item
Thrombocytopenia
boolean
C0040034 (UMLS CUI-1)
Kidney failure
Item
Severe renal impairment
boolean
C0035078 (UMLS CUI-1)
Liver failure
Item
Liver disease
boolean
C0085605 (UMLS CUI-1)
Pregnancy
Item
Positive pregnancy test
boolean
C0549206 (UMLS CUI-1)

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial